FDA-Approved Psychedelic for Depression
Psychedelic-assisted therapy is gaining recognition as an innovative and effective…
SPRAVATO®
Emerge Ketamine strives to keep ketamine treatment as affordable and accessible to as many people as possible.
Spravato is covered by the following insurance providers:
- Aetna
- Cigna
- BCBS of Mass
- Humana
- Mass Health
SPRAVATO® Patient Brochure
If you struggle with treatment-resistant depression, there are other options. SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat adults with treatment-resistant depression (TRD).
What is Spravato?
Spravato is a prescription nasal spray made of esketamine, a molecule derived from ketamine. Spravato was specifically developed for adults who haven’t responded to traditional medications or need rapid relief from suicidal thoughts.
Spravato works similarly to ketamine. However, it interacts more strongly with NMDA receptors—proteins in the brain that play a key role in how ketamine produces its effects.
Is SPRAVATO® Covered by Insurance?
Most insurance plans do cover Spravato. Emerge Ketamine does not bill your insurance company directly. Instead, patients are given a ‘super bill’ that they can send to their insurer for reimbursement.
Is SPRAVATO® FDA Approved?
Spravato was FDA approved for treatment resistant depression in 2019. In 2020 it was approved for use in adults with Major Depressive Disorder and Acute Suicidal Ideation.
Spravato is the only FDA-approved nasal spray for
adult patients with two forms of challenging-to-treat
major depressive disorder (MDD).
FDA Approved Treatment
Spravato was approved by the U.S. Food and Drug Administration in 2019 for treatment-resistant depression (TRD). It was approved for major depressive disorder with suicidal ideation (MDSI) one year later.
This approval means the FDA has reviewed the evidence and determined that Spravato is safe and effective for its intended use. Insurance-Backed Treatment Option
Because of its approval, Spravato is mostly covered by insurance. At Emerge, we’re in-network with several of the region’s leading insurance providers, helping lower costs and simplify the payment process.
This includes
- Aetna
- Cigna
- Blue Cross Blue Shield of Massachusetts
- Humana
- MassHealth
Not sure if you’re covered?
We’ll verify your benefits before starting treatment.
Our Services - Spravato
Is SPRAVATO® Covered by Insurance?
Most insurance plans do cover Spravato. Emerge Ketamine will bill your insurance company directly.
This includes
- Aetna
- Cigna
- BCBS of Mass
- Humana
- Mass Health
Who Can Benefit From Spravato?
Spravato is specifically approved for patients with a formal diagnosis of:
- Treatment-resistant depression – Have tried at least two standard antidepressants at an adequate dose and duration with no significant benefits
Major depressive disorder (MDD) with suicidal ideation – Clinical diagnosis of MDD and deemed to be at risk of suicide by a registered clinician
If you don’t meet the clinical diagnostic criteria for either of these conditions, then check out our IV ketamine services for an alternative option.
Let’s Get You Started
During your telemedicine consult, we’ll review your symptoms, verify your insurance, and help you decide if SPRAVATO® is right for you.
Does BCBS Cover Ketamine Therapy In Massachusetts?
Blue Cross Blue Shield (BCBS) is one of the leading…
We Also Offer Other Ketamine Treatments
Ketamine Treatments at Emerge
Are You a Candidate?
Request a consultation with Emerge Ketamine and discover if you are a candidate for ketamine treatments.
Let’s Get You Started
During your telemedicine consult, we’ll review your symptoms, verify your insurance, and help you decide if SPRAVATO® is right for you.
Get In touch
Contact Us for Pricing
During your initial telemedicine evaluation, we will answer any questions you have about IV ketamine therapy, and assess how it can enhance your healing.
